Copyright License
Licensing policy for Journal of Alzheimer's Research and Therapy (JALR) supports open access and author rights.
Open access with clear author ownership
JALR publishes under Creative Commons licensing to ensure that Alzheimer's research can be read, shared, and reused with proper attribution. Authors retain copyright while granting the journal and readers broad rights to distribute and build upon the work.
Licensing transparency helps readers, clinicians, and policy makers apply findings with confidence. This strengthens global reuse responsibly.
Articles in Journal of Alzheimer's Research and Therapy are published under the Creative Commons Attribution (CC BY) license unless alternative arrangements are approved in advance. CC BY allows unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Share and distribute
Readers may copy and redistribute published content in any format, including educational and clinical resources.
Adapt and build upon
Users may remix, transform, and build on articles for research, teaching, and innovation.
Attribution required
Reuse must include full citation of the article, authors, and Journal of Alzheimer's Research and Therapy.
Authors retain copyright and maintain control over their intellectual contributions. The journal license grants distribution rights while protecting author attribution.
- Authors may share the published article on personal, institutional, or funder repositories.
- Authors may reuse content in future publications with proper citation.
- Authors may translate the work or authorize translations with attribution.
- Educational and clinical use is permitted without additional permissions.
Authors must obtain permission for any third party content such as figures, tables, or instruments that are not their original work. Permissions should be documented and included at submission. If content cannot be licensed under CC BY, this must be clearly labeled in the figure legend or acknowledgments.
CC BY is generous, but it assumes that authors provide accurate source attribution and clarify any restrictions on third party content. Authors are responsible for confirming that all material can be distributed under the selected license. If portions of a manuscript cannot be shared under CC BY, these sections must be explicitly labeled to prevent misuse. Include license statements in supplementary files when relevant.
Open licensing allows educators and clinicians to integrate JALR content into training programs, patient education, and evidence based care resources. This is particularly important for Alzheimer's research, where rapid knowledge translation can improve diagnosis and support caregivers.
Authors may deposit the published version of record in institutional or funder repositories immediately after publication. This supports compliance with funder mandates and ensures long term access. When depositing, include the DOI and full citation to preserve accurate attribution and indexing.
In certain cases, authors may request alternative licensing such as CC BY NC when required by funders or institutional policies. Requests must be made during submission and will be evaluated by the editorial office. Approval is not guaranteed and depends on the journal's open access policies.
CC BY permits commercial reuse provided attribution is given. This enables responsible translation of findings into clinical tools, educational materials, or technologies. If authors have concerns about commercial reuse, they should discuss options with the editorial office during submission.
Proper attribution is required for all reuse. Citations should include the article title, author names, journal name, year of publication, and DOI. This protects author credit and ensures accurate tracking of impact.
Practical note: If your manuscript includes data sets or code with separate licenses, clearly state those licenses in the data availability section. Consistent licensing improves clarity for reuse.
Open licensing accelerates the translation of research into clinical guidelines, caregiver resources, and policy initiatives. It also enables systematic reviews and meta analyses that build on published evidence.
JALR encourages authors to consider how licensing choices may increase the reach and utility of their work, especially for underserved or resource limited communities.
Clear licensing also supports corrections and updates by ensuring that amended content can be distributed quickly with accurate attribution.
Questions about licensing?
Contact the editorial office at [email protected] for guidance on copyright and licensing requirements.
